Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".
Phase of Trial: Phase IV
Latest Information Update: 05 May 2017
At a glance
- Drugs Fenofibrate/simvastatin (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 24 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Jul 2015 New trial record